Buckwheat trypsin inhibitor
Buckwheat trypsin inhibitor has been studied in 3 papers since 2017: none in people yet, 3 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jun 1, 2026: “Buckwheat Trypsin Inhibitor Prolongs the Healthy Lifespan by Activating Mitochondrial Protein Import Stress in Caenorhabditis elegans”.
3 papers study it11 findingsUpdated
See all 3 papers on buckwheat trypsin inhibitor
At a glance
The findings reach worms or flies, none yet in people. 2 independent labs in 1 country.
None of its findings points the other way.
- 2 independent labs in 1 country
- Funders: National Institutes of Health and 3 more
- Model organisms3
What did studies of buckwheat trypsin inhibitor find?
10Studies of buckwheat trypsin inhibitor measured 10 outcomes, among them autophagy, Systemic metabolic reprogramming and ATP production.
Autophagy
upin worms2
2 studies
Autophagy
upin worms2
Buckwheat trypsin inhibitor activates autophagy in worms (inhibited by chloroquine in a reversal test).
Model organismsinhibited by chloroquine in a reversal testrecombinant
Buckwheat trypsin inhibitor activates autophagy in AD worms treated with rBTI.
Model organismsin AD worms treated with rBTI
Systemic metabolic reprogramming
upin worms1
1 study
Systemic metabolic reprogramming
upin worms1
Buckwheat trypsin inhibitor induces systemic metabolic reprogramming in worms with rewiring of amino acid and lipid metabolism.
Model organismswith rewiring of amino acid and lipid metabolismrecombinant
ATP production
upin worms1
1 study
ATP production
upin worms1
Buckwheat trypsin inhibitor increases ATP production in worms (dependent on K20 and K23 residues).
Model organismsdependent on K20 and K23 residuesrecombinant
daf-16
upin worms1
1 study
daf-16
upin worms1
Buckwheat trypsin inhibitor activates daf-16 in worms (measured by transcriptional activity of DAF-16).
Model organismsmeasured by transcriptional activity of DAF-16recombinant
Mitochondrial damage
downin worms1
1 study
Mitochondrial damage
downin worms1
Buckwheat trypsin inhibitor decreases mitochondrial damage in worms (N2 aging model and AM140 age-related disease model).
Model organismsN2 aging model and AM140 age-related disease modelrecombinant
Insoluble protein
downin worms1
1 study
Insoluble protein
downin worms1
Buckwheat trypsin inhibitor decreases insoluble protein in worms (N2 aging model and AM140 age-related disease model).
Model organismsN2 aging model and AM140 age-related disease modelrecombinant
Motor function
upin worms1
1 study
Motor function
upin worms1
Buckwheat trypsin inhibitor improves motor function in worms (N2 aging model and AM140 age-related disease model).
Model organismsN2 aging model and AM140 age-related disease modelrecombinant
Amyloid-beta
downin worms1
1 study
Amyloid-beta
downin worms1
Buckwheat trypsin inhibitor decreases amyloid-beta in AD worms treated with rBTI.
Model organismsin AD worms treated with rBTI
Paralysis
downin worms1
1 study
Paralysis
downin worms1
Buckwheat trypsin inhibitor decreases paralysis in AD model C. elegans (CL4176).
Model organismsin AD model C. elegans (CL4176)
Lifespan
upin worms1
1 study
Lifespan
upin worms1
Buckwheat trypsin inhibitor extends lifespan in AD model C. elegans (CL4176).
Model organismsin AD model C. elegans (CL4176)